ShareCompartir
Volume 13, Number 11—November 2007
Research
Methamphetamine Use and Methicillin-Resistant Staphylococcus aureus Skin Infections
Adam L. Cohen*
, Carrie Shuler*†, Sigrid McAllister*, Gregory E. Fosheim*, Michael G. Brown‡, Debra Abercrombie§, Karen Anderson*, Linda K. McDougal*, Cherie L. Drenzek†, Katie Arnold†, Daniel Jernigan*, and Rachel Gorwitz*
, Carrie Shuler*†, Sigrid McAllister*, Gregory E. Fosheim*, Michael G. Brown‡, Debra Abercrombie§, Karen Anderson*, Linda K. McDougal*, Cherie L. Drenzek†, Katie Arnold†, Daniel Jernigan*, and Rachel Gorwitz*
Table 1
Demographic characteristics of study participants with (case-patients) and without (controls) skin and soft tissue infections (SSTIs)*
| Characteristic | Patients with SSTIs |
Patients without SSTIs (N = 284), no. (%) | ||
|---|---|---|---|---|
| MRSA (N = 81), no. (%) | MSSA (N = 20), no. (%) | Other† (N = 18), no. (%) | ||
| Age, y | ||||
| <18 | 12 (14.8) | 0 | 2 (11.1) | 18 (6.3) |
| 19–34 | 30 (37.0) | 13 (65.0) | 8 (44.4) | 102 (35.9) |
| 35–64 | 35 (43.2) | 6 (30.0) | 7 (38.9) | 135 (47.5) |
| >65 | 4 (4.9) | 1 (5.0) | 1 (5.6) | 29 (10.2) |
| Male sex‡ | 48 (59.3)§ | 8 (40.0) | 10 (55.6) | 104 (36.6) |
| Race¶ | ||||
| White | 73 (90.1) | 18 (90.0) | 16 (88.9) | 244 (85.9) |
| Black | 5 (6.2) | 2 (10.0) | 2 (11.1) | 36 (12.7) |
| Other | 3 (3.7) | 0 | 0 | 3 (1.1) |
| Hispanic ethnicity# | 2 (2.5) | 0 | 0 | 4 (1.4) |
*MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus.
†Bacteria other than S. aureus isolated from SSTI in our investigation included other Staphylococcus spp., viridans group streptococci, Group B Streptococcus, Enterobacter cloacae, Stenotrophomonas maltophilia, and mixed flora.
‡6 records did not indicate sex (1 MRSA case, 1 MSSA case, and 4 controls).
§p<0.0001, when compared with controls.
¶For 1 control, race was not indicated.
#3 records did not indicate ethnicity (2 MRSA cases, 1 other skin infection).
- Page created: July 05, 2010
- Page last updated: July 05, 2010
- Page last reviewed: July 05, 2010
- Centers for Disease Control and Prevention,
-
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)